sinc
sever
acut
respiratori
syndrom
coronaviru
relat
diseas
spread
worldwid
need
share
insight
advic
continu
provid
optim
cancer
care
pandem
northern
itali
significantli
affect
outbreak
requir
immedi
emerg
measur
contain
spread
challeng
scenario
demand
major
effort
entir
health
system
measur
also
requir
address
medic
need
cancer
patient
inde
subject
high
mortal
repres
death
itali
suggest
need
special
precaut
pursuit
oncolog
treatment
variou
degre
flexibl
accept
standard
cancer
treatment
far
difficult
reconcil
phase
studi
strict
protocol
prescript
rapidli
evolv
scenario
prioriti
ensur
patient
safeti
maintain
high
scientif
rigor
commit
qualiti
drug
develop
depart
ask
make
decis
pandem
balanc
benefit
harm
immedi
discuss
sponsor
case
case
focus
potenti
impact
safeti
trial
particip
modifi
studi
logist
accordingli
studi
decis
includ
regard
continu
trial
recruit
reduc
patient
accrual
continu
treatment
patient
alreadi
enrol
drug
deliveri
home
need
chang
patient
monitor
trial
limit
access
hospit
due
gener
lockdown
case
guarante
trial
particip
kept
inform
chang
studi
monitor
plan
could
impact
ensur
safeti
trial
particip
healthcar
staff
paramount
import
us
provid
clinic
staff
addit
train
symptom
recognit
screen
procedur
use
person
protect
equip
phone
contact
day
visit
done
limit
hospit
access
patient
clear
symptom
facil
access
exclud
vendor
minim
ancillari
servic
visitor
medic
monitor
auditor
establish
triag
checkpoint
outsid
facil
clinic
offic
social
distanc
least
six
feet
apart
screen
patient
visitor
symptom
fever
enter
convert
current
open
infus
suit
semipriv
space
least
six
feet
distanc
patient
andor
use
avail
curtain
barrier
patient
move
virtual
platform
multidisciplinari
discuss
safeti
measur
fulli
implement
dealt
logist
issu
one
effect
measur
aim
contain
pandem
spread
social
isol
includ
quarantin
entir
area
travel
ban
norm
pose
signific
challeng
patient
resid
far
studi
center
demand
implement
flexibl
perform
experiment
clinic
procedur
therefor
set
solut
discuss
sponsor
overal
option
trial
procedur
eg
biopsi
withdrawn
biochem
radiolog
assess
permiss
sponsor
perform
accredit
closest
facil
patient
local
central
revis
scan
order
guarante
high
qualiti
data
experi
schedul
visit
clinic
site
significantli
impact
patient
outsid
region
certain
investig
product
distribut
selfadministr
agre
sponsor
altern
safe
deliveri
method
investig
product
normal
administ
health
care
set
intraven
subcutan
treatment
guarante
time
administr
local
patient
delay
within
window
treatment
patient
difficulti
access
facil
implement
telemedicin
intens
safeti
activ
monitor
patient
result
face
pandem
gener
huge
amount
protocol
deviat
parallel
mani
protocol
amend
submit
ethic
committe
approv
last
week
negoti
protocol
deviat
sponsor
twothird
concern
execut
exam
imag
procedur
onethird
delay
shipment
plan
treatment
deviat
protocol
rule
safeti
patient
prioriti
minim
avoid
risk
experi
suggest
pursu
conduct
pandem
potenti
feasibl
punctual
dictat
safeti
scientif
rigor
central
dogma
decis
align
global
nation
local
standard
social
contain
nonnegoti
implement
altern
process
consist
protocol
largest
possibl
extent
sponsor
clinic
investig
document
reason
conting
measur
dispos
sponsor
clinic
investig
document
restrict
relat
led
chang
studi
conduct
durat
chang
indic
trial
particip
impact
trial
particip
impact
develop
patientcent
set
safe
recommend
maintain
qualiti
research
pandem
thu
prioriti
oncolog
care
whenev
possibl
framework
close
cooper
stakehold
involv
pt
dt
declar
potenti
conflict
interest
relat
work
gc
receiv
honoraria
speaker
consult
advisori
rule
roch
pfizer
novarti
seattl
genet
lilli
ellips
pharma
foundat
medicin
samsung
